Source file signed link, expires in 15 minutes
Extracted text 2
Page 1
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
www.organon.com
PT ORGANON PHARMA INDONESIA TBK
PENGUMUMAN
RAPAT UMUM PEMEGANG SAHAM TAHUNAN
Dengan ini diumumkan kepada para Pemegang Saham PT Organon Pharma Indonesia Tbk
(“Perseroan”), berkedudukan di Sinarmas MSIG Tower, Lantai 37 Unit 102 & 106 Jl. Jend. Sudirman
Kav. 21 Setiabudi, Jakarta Selatan, DKI Jakarta, bahwa Perseroan akan menyelenggarakan
Pemegang Saham Perseroan untuk menghadiri Rapat Umum Pemegang Saham Tahunan
(“RUPST”) (selanjutnya disebut “Rapat”) di Jakarta pada hari Selasa, 10 Juni 2025.
Sesuai dengan ketentuan dalam Pasal 10 ayat 5 Anggaran Dasar Perseroan serta memperhatikan
Peraturan Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang Rencana dan
Penyelenggaraan Rapat Umum Pemegang Saham Perusahaan Terbuka (“POJK No. 15”),
Pemanggilan Rapat akan dilakukan pada 19 Mei 2025 melalui situs web Bursa Efek Indonesia, dan
situs web Perseroan.
Yang berhak menghadiri/mewakili dalam Rapat adalah Pemegang Saham Perseroan yang
namanya tercatat dalam Daftar Pemegang Saham Perseroan pada tanggal 16 Mei 2025, pukul
16.00 Waktu Indonesia Barat (WIB) atau pemilik saham Perseroan pada sub rekening efek PT
Kustodian Sentral Efek Indonesia (KSEI) pada penutupan perdagangan saham di Bursa Efek
Indonesia (BEI) tanggal 16 Mei 2025, pukul 16.00 WIB.
Seorang Pemegang Saham atau lebih yang (bersama-sama) mewakili 1/20 (satu per duapuluh)
atau lebih dari jumlah seluruh saham Perseroan dengan hak suara yang sah yang telah
dikeluarkan oleh Perseroan dapat mengajukan usulan mata acara Rapat. Usulan Pemegang
Saham Perseroan tersebut akan dimasukan dalam mata acara Rapat jika memenuhi ketentuan
Pasal 10 ayat 21 Anggaran Dasar Perseroan dan Pasal 16 POJK No. 15, yakni:
a. Usul tersebut diajukan tertulis dan diterima Direksi Perseroan paling lambat tanggal 11 Mei
2025 pukul 16.00 Waktu Indonesia Barat;
b.Disertai alasan dan bahan usulan mata acara Rapat;
c. Usul tersebut merupakan mata acara yang membutuhkan Keputusan Rapat serta tidak
bertentangan dengan peraturan perundang-undangan; dan
d.Usul tersebut dilakukan dengan itikad baik, mempertimbangkan kepentingan Perseroan dan
berhubungan langsung dengan usaha Perseroan.
Pengumuman Rapat ini juga dapat diakses pada situs web PT Kustodian Sentral Efek Indonesia
(www.ksei.co.id), situs web Bursa Efek Indonesia (www.idx.co.id), dan situs web Perseroan
(https://www.organon.com/indonesia/).
Jakarta, 2 Mei 2025
PT ORGANON PHARMA INDONESIA Tbk
Direksi
Page 2
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
www.organon.com
PT ORGANON PHARMA INDONESIA TBK
ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING OF
SHAREHOLDERS
It is hereby announced to the Shareholders of PT Organon Pharma Indonesia Tbk (the
"Company"), domiciled at Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav.
21 Setiabudi, Jakarta Selatan, DKI Jakarta, that the Company will hold an Annual General Meeting
of Shareholders (“AGMS”) (hereinafter referred to as the "Meeting") in Jakarta on Tuesday, 10
June 2025.
In accordance with the provisions of Article 10 paragraph 5 of the Company's Articles of
Association and Financial Services Authority Regulation Number 15/POJK.04/2020 concerning
Plans and Implementation of General Meeting of Shareholders of Public Companies ("POJK No.
15"), the invitation to the Meeting will be made on 19 May 2025 through the website of the
Indonesia Stock Exchange, and the Company's website.
Those entitled to attend/represent the Meeting are the Company's Shareholders whose names
are registered in the Company's Shareholders Register on 16 May 2025, 16.00 Western Indonesia
Time (WIB) or the Company's shareholders in the securities sub account PT Kustodian Sentral
Efek Indonesia (KSEI) at the close of trading day on the Indonesia Stock Exchange (IDX) on 16
May 2025, 16.00 WIB.
One or more Shareholders who (together) represent 1/20 (one twentieth) or more of the total
number of shares of the Company with valid voting rights that have been issued by the
Company may propose a meeting agenda. The proposal of the Company's Shareholders will be
included in the agenda of the Meeting if it meets the provisions of Article 10 paragraph 3 of the
Company's Articles of Association and Article 16 of POJK No. 15, namely:
a. The proposal is submitted in writing and received by the Board of Directors of the
Company no later than 11 May 2025, at 16.00 Western Indonesian Time (WIB);
b. Accompanied by the reasons and materials for the proposed agenda items of the Meeting;
c. The proposal is an agenda item that requires Meeting Resolutions and does not conflict
with statutory regulations; and
d. The proposal was made in good faith, taking into account the interests of the Company
and directly related to the Company's business.
The announcement of this Meeting can also be accessed on the website of the Indonesian
Central Securities Depository (www.ksei.co.id), the website of the Indonesia Stock Exchange
(www.idx.co.id), and the Company's website (https://www.organon.com/indonesia/).
Jakarta, 2 May 2025
PT ORGANON PHARMA INDONESIA Tbk
Board of Directors
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Kustodian Sentral Efek Indonesia
p.1 ×5
unresolved
org
Financial Services Authority
p.2
unresolved
org
Indonesia Stock Exchange
p.2 ×3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
Rule parser
Needs review
confidence 0.333
646 ms
12 Sep 2026 22:51
no shares_present; no pct_present; no vote table found
Raw output
{'agenda': [],
'is_electronic': False,
'meeting_date': '2025-06-10',
'meeting_type': 'AGM',
'record_date': '2025-05-16'}